Moreover, the proportion of CD11b+F4/80+ myeloid cells, referred to as tumor-associated macrophages (TAMs), showed a tendency of elevated frequency in NY-BR-1 expressing tumors comprising up to 70% of CD45+ leukocytes (Fig. 2a right). This evidence concerns the gene ANKRD30A and neoplasm.